Overview

Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders Patients

Status:
Unknown status

Trial end date:
2020-09-01

Target enrollment:

Participant gender:

Summary

The main goal of this study is evaluate the efficacy of memantine association on the treatment with a previous combination of two drugs, including quetiapine with lithium or quetiapine with aripiprazole in young patients with bipolar disorder type 1 non-responders or partial responders to that combination of drugs and evaluate the impact of this association at the cognitive functioning of the patients.

Phase:

Phase 2

Details

Lead Sponsor:

University of Sao Paulo

Treatments:

Aripiprazole
Lithium Carbonate
Memantine
Quetiapine Fumarate